Clinical trial
Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
NCT00032890 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00032890 |
|---|---|
| Title | Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) |
| Official title | Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | glucosamine, chondroitin sulfate, glucosamine and chondroitin sulfate combined, celecoxib |
| Enrollment | 1,588 |
| Start date | Apr 1, 2000 |
| Completion | Feb 1, 2004 |
| First posted | Apr 8, 2002 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: